$2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.46 -0.05 (9.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.51 | 52 Week High | $16.54 | |||
| Open | $0.47 | 52 Week Low | $8.10 | |||
| Day High | $0.49 | P/E | N/A | |||
| Day Low | $0.46 | EPS | $0.00 | |||
| Volume | 147,232 | |||||
| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.46 -0.05 (9.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.51 | 52 Week High | $16.54 | |||
| Open | $0.47 | 52 Week Low | $8.10 | |||
| Day High | $0.49 | P/E | N/A | |||
| Day Low | $0.46 | EPS | $0.00 | |||
| Volume | 147,232 | |||||
